A blood-test approach for a hard-to-see injury
Traumatic brain injury can be difficult to assess in the emergency department, particularly when a head CT scan does not show an obvious acute injury. A multi-institutional research team led by clinician-scientists at the University of Pittsburgh School of Medicine has reported clinical cutoffs for two brain-associated proteins detected in blood after injury. The work, published in the Journal of Neurosurgery, is intended to help clinicians identify and triage people with traumatic brain injury more effectively.
The researchers’ goal is not to displace imaging. CT scans remain a common first-line tool because they are widely available, relatively inexpensive and able to quickly identify acute injuries. Instead, blood-based biomarkers could provide another objective signal when symptoms, examination findings and imaging do not fully capture the injury.
Why identification matters
About 2.8 million people in the United States experience traumatic brain injury each year, according to the report. The condition can bring substantial mortality, morbidity and long-term disability. The challenge is especially acute for people with mild injuries, whose CT scans may not reveal a clear abnormality even though they later experience functional limitations.
Previous findings from the multicenter TRACK-TBI study found that more than half of participants with a mild brain injury had functional limitations one year later. Shawn Eagle, an assistant professor in Pittsburgh’s Department of Neurological Surgery and lead author of the new study, said poor long-term outcomes may partly reflect failures to identify patients properly at the outset.
Before this line of research, Eagle said, clinicians lacked an objective way to identify a brain injury when CT imaging was negative. That limitation matters because an apparently reassuring scan can shape decisions about observation, referral and escalation of care. A blood test that better distinguishes risk could help make those decisions more consistent.
Built on a multicenter research effort
The study draws on TRACK-TBI, a longitudinal, multicenter effort that collects clinical information and biospecimens from people who present to emergency departments with traumatic brain injury. The University of Pittsburgh’s Neurotrauma Clinical Trials Center serves as the study’s primary biorepository.
By linking blood measurements with clinical data, the team sought cutoffs that could be useful in real-world assessment rather than simply showing that biomarker levels differ between groups. The reported thresholds concern two proteins associated with the brain and detected in blood after injury. Their proposed role is to support better identification and triage of patients whose injuries might otherwise be missed.
What the result does—and does not—mean
The findings point toward a more layered approach to emergency evaluation: symptoms and examination, imaging when appropriate, and blood biomarkers as an additional source of evidence. Such a system could be particularly valuable when a patient’s CT scan does not resolve the clinical question.
However, the study does not establish that a blood test alone can diagnose every traumatic brain injury or replace clinical judgment. The researchers describe the work as part of an effort to expand use of blood-based biomarker tests and improve escalation of care. Further adoption will depend on how the cutoffs perform across care settings and how they are integrated into clinical workflows.
The larger clinical opportunity
For patients, the potential value is earlier recognition of injuries that are easy to underestimate. For clinicians, an objective blood-based measure could complement the rapid structural information provided by CT. And for health systems, better initial classification could help target follow-up and support to people at risk of persistent problems.
The new research therefore addresses a central gap in traumatic brain injury care: the distance between a negative scan and a patient’s later outcome. By establishing clinically oriented biomarker cutoffs, the team is aiming to give emergency clinicians another tool for deciding who may need closer attention after a head injury.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
